Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2563778

CRYSTALLINE FORM OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDEROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    25.3.2011
  • EP published:
    24.8.2016
  • EP application number:
    11713134.2
  • Max expiry date:
    24.3.2031
  • Title:
    CRYSTALLINE FORM OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDEROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE

Timeline

Today
25.3.2011EP application
24.8.2016EP Publication

Owner

  • Name:
    Vertex Pharmaceuticals Incorporated
  • Address:
    50 Northern Avenue, 02210, Boston, MA, US

Inventor

  • Name:
    KESHAVARZ-SHOKRI, Ali
  • Address:
    San DiegoCA, US
  • Name:
    ZHANG, Beili
  • Address:
    San DiegoCA, US
  • Name:
    ALCACIO, Tim, Edward
  • Address:
    San DiegoCA, US
  • Name:
    LEE, Elaine, Chungmin
  • Address:
    MA, US
  • Name:
    ZHANG, Yuegang
  • Address:
    WaylandMA, US
  • Name:
    KRAWIEC, Mariusz
  • Address:
    MarlboroughMA, US

Priority

  • Number:
    321636 P
  • Date:
    7.4.2010
  • Country:
    US
  • Number:
    321561 P
  • Date:
    7.4.2010
  • Country:
    US
  • Number:
    319953 P
  • Date:
    1.4.2010
  • Country:
    US
  • Number:
    317376 P
  • Date:
    25.3.2010
  • Country:
    US

Classification

  • Categories:
    C07D 405/12, A61K 31/404, A61P 11/00

Upload documents